Raymond James & Associates NABRIVA THERAPEUTICS PLC Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
N/A
-37,150 Closed
0 $0
Q3 2020

Nov 04, 2020
SELL
N/A
-3,500 Reduced 8.61%
37,150 $20,000
Q1 2020

Apr 21, 2020
BUY
N/A
1,000 Added 2.52%
40,650 $23,000
Q4 2019

Feb 12, 2020
BUY
N/A
39,650 New
39,650 $52,000
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email